Measurable Residual Disease-Guided Treatment to Prevent Relapse in Acute Myeloid Leukemia and Myelodysplastic Syndrome
oleh: Jonathan Pan, Daniel Altman, Lindsay Wilde
| Format: | Article |
|---|---|
| Diterbitkan: | Frontiers Media S.A. 2020-10-01 |
Deskripsi
Subjek
acute myeloid leukemia; myelodysplastic syndrome; measurable residual disease; hypomethylating agents; azacitidine; stem-cell transplant